ProfileGDS5678 / 1429087_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 47% 48% 48% 49% 48% 46% 46% 48% 48% 49% 48% 49% 45% 48% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1551347
GSM967853U87-EV human glioblastoma xenograft - Control 23.139748
GSM967854U87-EV human glioblastoma xenograft - Control 33.1435648
GSM967855U87-EV human glioblastoma xenograft - Control 43.103749
GSM967856U87-EV human glioblastoma xenograft - Control 53.0943248
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1689746
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.137246
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1201348
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.1158448
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1340849
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.1227148
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.1178349
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0563345
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.1314848